10-Q 1 form10q_063005.htm FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2005 Form 10-Q for the Quarter Ended June 30, 2005



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

 
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the Quarterly Period Ended June 30, 2005
 
OR
 
 
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 000-27945


ASCENDANT SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)


Delaware
 
75-2900905
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)


16250 Dallas Parkway, Suite 205, Dallas, Texas
 
75248
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: 972-250-0945
 
 16250 Dallas Parkway, Suite 102, Dallas, Texas 75248
(Former Name or Former Address, if Changed Since Last Report)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No o
 
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes o No x
 
At August 1, 2005 there were approximately 21,980,900 shares of Ascendant Solutions, Inc. common stock outstanding.
 



ASCENDANT SOLUTIONS, INC.
 
FORM 10-Q
 
For the Quarterly Period Ended June 30, 2005
 





ASCENDANT SOLUTIONS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(000’s omitted, except share amounts)

   
June 30,
 
December 31,
 
   
2005
 
2004
 
   
(Unaudited)
     
ASSETS
 
Current assets:
             
Cash and cash equivalents
 
$
1,239
 
$
1,868
 
Trade accounts receivable, net
   
5,288
   
6,350
 
Other receivables
   
223
   
161
 
Receivable from affiliates
   
83
   
71
 
Inventories
   
2,520
   
2,498
 
Prepaid expenses
   
622
   
503
 
     
9,975
   
11,451
 
Property and equipment, net
   
1,015
   
716
 
Goodwill
   
7,299
   
7,299
 
Other intangible assets
   
592
   
758
 
Investments in limited partnerships, net
   
1,457
   
410
 
Other assets
   
100
   
119
 
Total assets
 
$
20,438
 
$
20,753
 
               
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
             
Accounts payable
 
$
1,808
 
$
1,633
 
Accounts payable to affiliates
   
88
   
-
 
Accrued expenses
   
2,603
   
3,161
 
Notes payable, current
   
481
   
461
 
     
4,980
   
5,255
 
Notes payable, long-term
   
11,807
   
12,155
 
Limited partnership and minority interests
   
665
   
464
 
Contingent indemnification liability
   
220
   
-
 
Total liabilities
   
17,672
   
17,874
 
Commitments and contingencies
             
Stockholders' equity:
             
Preferred stock, $0.0001 par value:
             
Authorized shares--7,500,000, issued and outstanding--none
   
-
   
-
 
Common stock, $0.0001 par value:
             
Authorized shares--50,000,000, issued and outstanding shares--21,980,900 and 21,933,400 at June 30, 2005 and December 31, 2004, respectively.
   
2
   
2
 
Additional paid-in capital
   
60,030
   
59,961
 
Deferred compensation
   
(112
)
 
(78
)
Accumulated deficit
   
(57,154
)
 
(57,006
)
Total stockholders' equity
   
2,766
   
2,879
 
Total liabilities and stockholders' equity
 
$
20,438
 
$
20,753
 
               
See accompanying notes to the Condensed Consolidated Financial Statements.
 


ASCENDANT SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(000's omitted, except share and per share amounts)
(Unaudited)

   
Three Months Ended
 
Six Months Ended
 
   
June 30,
 
June 30,
 
   
2005
 
2004
 
2005
 
2004
 
                   
Revenue:
                         
Healthcare
 
$
9,892
 
$
9,895
 
$
19,717
 
$
10,670
 
Real estate advisory services
   
2,684
   
2,390
   
6,128
   
3,067
 
     
12,576
   
12,285
   
25,845
   
13,737
 
Cost of sales:
                         
Healthcare
   
6,674
   
6,435
   
13,326
   
6,942
 
Real estate advisory services
   
1,783
   
1,314
   
3,832
   
1,521
 
     
8,457
   
7,749
   
17,158
   
8,463
 
                           
Gross profit
   
4,119
   
4,536
   
8,687
   
5,274
 
                           
Operating expenses:
                         
Selling, general and administrative expenses
   
4,086
   
4,074
   
8,256
   
4,929
 
Non-cash stock compensation
   
20
   
8
   
35
   
18
 
Depreciation and amortization
   
165
   
84
   
322
   
90
 
                           
Total operating expenses
   
4,271
   
4,166
   
8,613
   
5,037
 
                           
Operating income (loss)
   
(152
)
 
370
   
74
   
237
 
                           
Investment income
   
117
   
70
   
194
   
140
 
Interest expense, net
   
(189
)
 
(162
)
 
(367
)
 
(165
)
Loss on sale of equipment
   
-
   
(17
)
 
(1
)
 
(17
)
Income (loss) before limited partnership and
                         
minority interest and income tax expense
   
(224
)
 
261
   
(100
)
 
195
 
Limited partnership and minority interest loss (income)
   
17
   
1
   
29
   
(39
)
State income tax expense
   
17
   
48
   
77
   
48
 
Net income (loss)
 
$
(224
)
$
214
 
$
(148
)
$
108
 
                           
Basic net income (loss) per share
 
$
(0.01
)
$
0.01
 
$
(0.01
)
$
0.00
 
                           
Diluted net income (loss) per share
 
$
(0.01
)
$
0.01
 
$
(0.01
)
$
0.00
 
                           
Shares used in computing basic net income (loss) per share
   
21,965,067
   
21,732,567
   
21,949,233
   
21,699,233
 
                           
Shares used in computing diluted net income (loss) per share
   
21,965,067
   
22,013,358
   
21,949,233
   
21,989,342
 
                           
See accompanying notes to the Condensed Consolidated Financial Statements.

 

 


ASCENDANT SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(000's omitted)
(Unaudited)
   
Six Months Ended
 
   
June 30,
 
   
2005
 
2004
 
Operating Activities
         
Net income (loss)
 
$
(148
)
$
108
 
Adjustments to reconcile net income (loss) to net cash
             
provided by operating activities:
             
Provision for doubtful accounts
   
169
   
267
 
Depreciation and amortization
   
322
   
90
 
Deferred compensation amortization
   
35
   
17
 
Non-cash stock option compensation
   
-
   
18
 
Loss on sale of property and equipment
   
1
   
17
 
Limited partnership and minority interest
   
(29
)
 
39
 
Changes in operating assets and liabilities, net of
             
effects from acquisitions:
             
Accounts receivable
   
893
   
863
 
Inventories
   
(22
)
 
(112
)
Prepaid expenses and other assets
   
(174
)
 
(103
)
Accounts payable
   
263
   
481
 
Accrued expenses
   
(558
)
 
(108
)
Net cash provided by operating activities
   
752
   
1,577
 
Investing Activities
             
Return of capital distributions
   
18
   
18
 
Proceeds from sale of property and equipment
   
-
   
39
 
Deferred acquisition costs
   
-
   
310
 
Net cash acquired in acquisitions
   
-
   
1,537
 
Purchases of property and equipment
   
(456
)
 
(22
)
Distributions to limited partners
   
-
   
(31
)
Investment in limited partnerships
   
(845
)
 
(97
)
Payment of acquisition liabilities
   
-
   
(1,350
)
Purchase cost of acquisitions, net of cash acquired
   
-
   
(795
)
Net cash used in investing activities
   
(1,283
)
 
(391
)
Financing Activities
             
Proceeds from exercise of common stock purchase options
   
-
   
48
 
Proceeds from sale of limited partnership interests
   
230
   
230
 
Proceeds from notes payable
   
30
   
-
 
Payments on notes payable
   
(358
)
 
(385
)
Net cash used in financing activities
   
(98
)
 
(107
)
Net increase (decrease) in cash and cash equivalents
   
(629
)
 
1,079
 
Cash and cash equivalents at beginning of period
   
1,868
   
2,006
 
               
Cash and cash equivalents at end of period
 
$
1,239
 
$
3,085
 
Supplemental Cash Flow Information
             
Cash paid for state income taxes
 
$
269
 
$
-
 
Cash paid for interest on notes payable
 
$
396
 
$
-
 
Noncash investing activities
             
Indemnification liability recorded
 
$
220
 
$
-
 
See accompanying notes to the Condensed Consolidated Financial Statements.


ASCENDANT SOLUTIONS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
1. Basis of Presentation
 
The unaudited condensed consolidated financial statements included herein reflect all adjustments, consisting only of normal recurring adjustments, which in the opinion of management are necessary to fairly state Ascendant Solutions, Inc.’s (“Ascendant Solutions” or the “Company”) consolidated financial position, consolidated results of operations and consolidated cash flows for the periods presented. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Form 10-K for the year ended December 31, 2004 as filed with the Securities and Exchange Commission. The consolidated results of operations for the three and six month periods ended June 30, 2005, respectively, are not necessarily indicative of the results to be expected for any subsequent quarter or for the entire fiscal year ending December 31, 2005. The December 31, 2004 consolidated balance sheet was derived from audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. Terms not otherwise defined herein shall have the meaning given to them in the Company’s Form 10-K for the year ended December 31, 2004 as filed with the Securities and Exchange Commission.
 
2. Description of Business
 
Ascendant Solutions is a diversified financial services company which is seeking to, or has invested in or acquired, healthcare, manufacturing, distribution or service companies. The Company also conducts various real estate activities, performing real estate advisory services for corporate clients, and, through an affiliate, purchase real estate assets, as a principal investor.

The Company is organized in three segments: (i) healthcare, (ii) real estate services and (iii) corporate and other businesses. The following is a summary of the Company’s identifiable business segments, consolidated subsidiaries and their related business activities:

Business Segment
Subsidiaries
Principal Business Activity
Healthcare
Dougherty’s Holdings, Inc. and Subsidiaries (“DHI”)
Healthcare products and services provided through retail pharmacies and infusion therapy centers, including specialty compounding pharmacy services
Real estate advisory services
CRESA Partners of Orange County, L.P., ASDS of Orange County, Inc.,
CRESA Capital Markets Group, L.P.
Tenant representation, lease management services, capital markets advisory services and strategic real estate advisory services
Corporate & other
Ascendant Solutions, Inc.,
ASE Investments Corporation,
VTE, L.P.
Corporate administration, investments in Ampco Partners, Ltd., Fairways Frisco, L.P. and Fairways 03 New Jersey, L.P.
 
Through early 2001, the Company had been engaged in providing call center, order management and fulfillment services, portions of which were sold or otherwise wound down by July 1, 2001. From July 1, 2001 and continuing through December 31, 2002, the Company had no revenue producing contracts or operations. In December 2001, the Company revised its strategic direction to seek acquisition possibilities throughout the United States or enter into other business endeavors.


During 2002, the Company made its first investments, and it has continued to make additional investments and acquisitions throughout 2003 and 2004. A summary of the Company’s investment and acquisition activity is shown in the table below:

Date
 Entity
Business Segment
Transaction Description
% Ownership
April 2002
Ampco Partners, Ltd
Corporate & other
Investment in a non-sparking, non-magnetic safety tool manufacturing company
10%
August 2002
VTE, L.P.
Corporate & other
Investment to acquire early stage online electronic ticket exchange company
23%
October 2002
CRESA Capital Markets Group, L.P.,
ASE Investments Corporation
Real estate advisory services
Investment to form real estate capital markets and strategic advisory services companies
80%
November 2003
Fairways 03 New Jersey, L.P.
Corporate & other
Investment in a single tenant office building
20%
March 2004
Dougherty’s Holdings, Inc. and Subsidiaries
Healthcare
Acquisition of specialty pharmacies and therapy infusion centers
100%
April 2004
Fairways 36864, L.P.
Corporate & other
Investment in commercial real estate properties
20%
May 2004
CRESA Partners of Orange County, L.P.,
ASDS of Orange County, Inc.
Real estate advisory services
Acquisition of tenant representation and other real estate advisory services company
99%
December 2004
Fairways Frisco, L.P.
Corporate & other
Investment in a mixed-use real estate development
14%1

1 The Company was the initial limited partner in Fairways Frisco, L.P., which obtained a 50% ownership interest in the Frisco Square Partnerships on December 31, 2004. Fairways Frisco, L.P. subsequently sold additional limited partnership interests and the Company held a limited partnership interest of approximately 14% in Fairways Frisco, L.P. as of June 30, 2005. See Note 10 for additional information regarding Fairways Frisco, L.P. and the Frisco Square Partnerships.

Certain of these transactions involved related parties or affiliates as more fully described in the Company’s consolidated financial statements included in the Company’s Form 10-K for the year ended December 31, 2004.

The Company will continue to look for acquisition opportunities, however, its current cash resources are limited and it will be required to expend significant executive time to assist the management of recently acquired businesses. The Company will continue seeking to (1) most effectively deploy its remaining cash, debt capacity (if any) and (2) capitalize on the experience and contacts of its officers and directors.

Please see Note 16 “Business Segment Information” in the notes hereto for additional information.
 


Summary of Significant Accounting Policies
 
Basis of Presentation  
The condensed consolidated financial statements include the accounts of Ascendant Solutions, Inc. and all subsidiaries for which the Company has significant influence over operations. All intercompany balances and transactions have been eliminated. The limited partnership interests for the subsidiaries and related minority interests are included on the balance sheet as Limited Partnership and Minority Interests.  

Use of Estimates  
The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported consolidated financial statements and accompanying notes, including allowance for doubtful accounts, inventory reserves and contingent liability recorded under an indemnification agreement. Actual results could differ from those estimates.  

Cash and Cash Equivalents  
The Company classifies all highly liquid investments with original maturities of three months or less as cash equivalents. Cash equivalents are stated at cost, which approximates fair value.  

Concentration of Credit Risk
The Company’s credit risk relates primarily to its trade accounts receivables and its receivables from affiliates, along with cash deposits maintained at financial institutions in excess of federally insured limits. Management performs continuing evaluations of debtors’ financial condition and provides an allowance for uncollectible accounts as determined necessary. See Note 5 for additional information regarding the Company’s trade accounts receivable, allowance for doubtful accounts and significant customer relationships.

Property and Equipment  
Property and equipment is carried at cost. Depreciation and amortization are provided over the estimated useful lives of the assets (generally three to seven years) using the straight-line method. Leasehold improvements are amortized on a straight-line basis over the lesser of the respective lease term or estimated useful life of the asset.  See Note 8 for additional information regarding property and equipment.

Inventories
Inventories consists of healthcare product finished goods held for resale, valued at the lower of cost, using the first-in, first-out method, or market. The Company provides an estimated reserve against inventory for excess, slow moving and obsolete inventory as well as inventory whose carrying value is in excess of its net realizable value. See Note 6 for additional information regarding inventories.

Long-Lived Assets  
The Company evaluates the carrying value of its long-lived assets by comparing the undiscounted cash flows over the remaining useful life of the long-lived assets with the assets’ carrying value. If this comparison indicates that the carrying value will not be recoverable, the carrying value of the long-lived assets will be reduced accordingly based on a discounted cash flow analysis. No impairment was recorded during the three month and six month periods ended June 30, 2005.

Investments in Limited Partnerships  
Investments in limited partnerships include the Company’s investments in Ampco and Fairways Frisco, L.P., and none represent investments in publicly traded companies. The investment in Ampco is accounted for using the equity method of accounting for investments. The equity method is used as the Company does not have a majority interest and does not have significant influence over the operations of Ampco. Distributions received by the Company are recorded as investment income on the condensed consolidated statement of operations to the extent the distribution does not exceed the Company’s proportionate share of the investee’s earnings. Distributions in excess of the Company’s proportionate share are recorded as a reduction of the Company’s investment. 



The Company utilizes the cost method to account for its investment in Fairways Frisco, L.P. Its ownership is less than 15% and it does not have any involvement in, nor does it exercise significant influence over the operations of Fairways Frisco, L.P. The Frisco Square Partnerships will require additional funding from Fairways Frisco, L.P. in order to continue development of its real estate. However, the Company is not obligated to invest any additional funds if Fairways Frisco, L.P. makes a capital call for additional cash. The Company expects its ownership percentage in Fairways Frisco, L.P. will decline further if additional capital calls are received for Fairways Frisco, L.P.’s funding needs and the Company does not fund its pro-rata share of such funding needs. Management believes that the cost method of accounting for its investment in Fairways Frisco, L.P. provides an accurate reflection of the nature of its investment and the current and future economic interest of the investment. As such, the investment is recorded at its actual cost. Any distributions received from Fairways Frisco, L.P. will be recorded as income when received. However, the Company does not expect to receive any distributions from Fairways Frisco, L.P. for the foreseeable future. For the three month and six month periods ended June 30, 2005, there were no limited partner distributions received from this investment. See Note 10 for additional information regarding the Company’s investment in Fairways Frisco, L.P.

The Company’s recorded investment in Fairways 03 New Jersey, LP is due to its limited indemnification obligation to its partners in the Fairways 03 New Jersey LP investment for any losses those partners may incur under their personal guaranties of the partnership’s bank indebtedness is subject to the provisions of FIN 45. In the first quarter of 2005, the Company estimated its obligation under this indemnification agreement to be $220,000 and recorded this amount as a contingent liability and an increase to its investment in limited partnerships. At the present time, the Company does not believe it is probable that any defaults will occur on the bank debt subject to this guaranty and indemnification agreement. The Company’s maximum liability, if any, under this limited indemnification is $520,000. See Note 13 for additional information regarding the Company’s indemnification obligation.

Revenue Recognition  
Healthcare revenues are reported at the estimated net realizable amounts expected to be received from individuals, third-party payors, institutional healthcare providers and others. The Company recognizes revenue from the sale of pharmaceutical products and retail merchandise as transactions occur and product is delivered to the customer. Revenue from product sales is recognized at the point of sale and service revenue is recognized at the time services are provided.
  
Real estate advisory services revenue is primarily from brokerage commissions earned from project leasing and tenant representation transactions. Brokerage commission revenue is generally recorded upon execution of a lease contract, unless additional activities are required to earn the commission pursuant to a specific brokerage commission agreement. Participation interests in rental income are recognized over the life of the lease. Other revenue is recognized as the following consulting services are provided: facility and site acquisition and disposition, lease management, design, construction and development consulting, move coordination and strategic real estate advisory services. Participation interests in rental income are recognized over the life of the lease.

Income Taxes  
The Company’s income taxes are presented utilizing an asset and liability approach, and deferred taxes are determined based on the estimated future tax effects of differences between the financial statement and tax bases of assets and liabilities given the provisions of the enacted tax laws. Valuation allowances are established for deferred tax assets where management believes it is more likely than not that the deferred tax asset will not be realized.

Net Income (Loss) Per Share  
Basic and diluted net income (loss) per share is computed based on the loss applicable to common stockholders divided by the weighted average number of shares of common stock outstanding during each period. Potentially dilutive securities consisting of warrants and stock options were not included in the calculation for the three month and six month periods ended June 30, 2005 as their effect is anti-dilutive. The number of dilutive shares resulting from assumed conversion of stock options and warrants are determined by using the treasury stock method.  See Note 3 for more information regarding the calculation of net income (loss) per share.



Impairment of goodwill and other intangible assets
The Company has adopted a policy of recording an impairment loss on goodwill and other intangible assets when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amount. Goodwill and other intangible assets are assessed for impairment on at least an annual basis by management.

Recent Accounting Pronouncements
In December 2004, the Financial Accounting Standards Board issued FASB Statement No. 123R (Revised 2004), Share-Based Payment., which requires that the compensation cost relating to share-based payment transactions such as options, restricted share plans, performance based awards, share appreciation rights and employee share purchase plans be recognized in financial statements. That cost will be measured based on the fair value of the equity or liability instruments issued. The Company will be required to apply Statement 123R beginning in the 1st quarter of 2006.

Statement 123R replaces FASB Statement No. 123, Accounting for Stock-Based Compensation and supersedes APB Opinion No. 25, Accounting for Stock Issued to Employees. Statement 123, as originally issued in 1995, established as preferable a fair-value-based method of accounting for share-based payment transactions with employees. However, that statement permitted entities the option of continuing to apply the guidance in Opinion 25, as long as the footnotes to the financial statements disclosed what net income would have been had the preferable fair-value-based method been used.

The Company currently expenses the cost of restricted shares issued to employees and directors over the service vesting period associated with the restricted shares. The Company currently has no options outstanding which are not vested. As a result, management does not believe the implementation of Statement 123R will have a material impact on its results of operations.

In November 2002, the Financial Accounting Standards Board issued Interpretation No. 45 (“FIN 45”), Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others, an Interpretation of FASB Statements No. 5, 57, and 107 and Rescission of FASB Interpretation No. 34. FIN 45 clarifies the requirements of SFAS No. 5 relating to the guarantors accounting for and disclosure of the issuance of certain types of guarantees. This interpretation clarifies that a guarantor is required to recognize at the inception of certain types of guarantees, a liability for the fair value of the obligation undertaken in issuing the guarantee, and requires disclosures on existing guarantees even if the likelihood of future liability under the guarantees is deemed remote. The initial recognition and initial measurement provisions of FIN 45 are applicable on a prospective basis for all guarantees issued after December 31, 2002.

Stock Based Compensation  
The Company accounts for its employee stock options and stock based awards utilizing the intrinsic value method, whereby, if the exercise price of an employee’s stock option equals or exceeds the market price of the underlying stock on the date of the grant, no compensation expense is recognized. In October 1995, the Financial Accounting Standards Board issued Statement No. 123, Accounting for Stock-Based Compensation (“SFAS No. 123”), which establishes a fair value-based method of accounting for stock-based compensation plans. The Company has adopted the disclosure-only alternative under SFAS No. 123. The Company accounts for stock based compensation to non-employees using the fair value method in accordance with SFAS No. 123 and Emerging Issues Task Force (EITF) Issue No. 96-18. The Company has recognized deferred stock compensation related to certain stock option and grants of restricted stock. During 2002, the Company granted 1,310,000 options, on a net basis, to purchase shares of common stock at $0.24 per share. The Company valued these options based on the Black-Scholes option pricing model.
 
The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of SFAS Statement No. 123, Accounting for Stock-Based Compensation, to stock-based compensation.


  
   
Three Months Ended June 30,
 
Six Months Ended June 30,
 
   
2005
 
2004
 
2005
 
2004
 
Net income (loss) attributable to common stockholders as reported
 
$
(224,000
)
$
214,000
 
$
(148,000
)
$
108,000
 
Total stock-based employee compensation included in reported net income (loss), net of related tax effects
   
20,000
   
8,000
   
35,000
   
18,000
 
Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects
   
(3,000
)
 
(84,000
)
 
(6,000
)
 
(91,000
)
Pro forma net income (loss)
 
$
(207,000
)
$
138,000
 
$
(119,000
)
$
35,000
 
                           
Net income (loss) per share:
                         
Basic - as reported
 
$
(0.01
)
$
0.01
 
$
(0.01
)
$
0.00
 
Basic - pro forma
 
$
(0.01
)
$
0.01
 
$
(0.01
)
$
0.00
 
Diluted - as reported
 
$
(0.01
)
$
0.01
 
$
(0.01
)
$
0.00
 
Diluted - pro forma
 
$
(0.01
)
$
0.01
 
$
(0.01
)
$
0.00
 

The Company used the Black-Scholes option-pricing model to determine the fair value of grants made during 2002. The following weighted average assumptions were applied in determining the pro forma compensation cost: risk free interest rate - 4.69%, expected option life in years - 6.00, expected stock price volatility - 1.837 and expected dividend yield - 0.00%.

Fair Value of Financial Instruments  
The Company’s financial instruments include cash, accounts receivable and accounts payable that are carried at cost, which approximates fair value because of the short maturity of these instruments. The fair value of notes payable approximates carrying value as interest rates approximate market rates. The fair value of investments in limited partnerships is not readily determinable without undue cost.

Reclassifications
Certain prior year balances have been reclassified to conform to the current year presentation. 

3. Computation of Basic and Diluted Net Income (Loss) Per Common Share
 
Basic income (loss) per common share is based on the net income (loss) divided by the weighted average number of common shares outstanding during the period. Diluted income (loss) per common share is based on the net income (loss) divided by the weighted average number of common shares including equivalent common shares of dilutive common stock options and warrants outstanding during the period. No effect has been given to outstanding options or warrants in the diluted computation, for the three or six month period ended June 30, 2005, as their effect would be anti-dilutive due to the net loss. The number of potentially dilutive stock options and warrants excluded from the computation for the three and six month periods ended June 30, 2005 was approximately 1,066,000 and 1,019,000, respectively. A reconciliation of basic and diluted income (loss) per common share follows:



   
Three Months Ended June 30,
 
Six Months Ended June 30,
 
   
2005
 
2004
 
2005
 
2004
 
                   
Net income (loss)
 
$
(224,000
)
$
214,000
 
$
(148,000
)
$
108,000
 
                           
Weighted average number
                         
of shares outstanding
                         
used in computing basic
                         
net income (loss) per share
   
21,965,067
   
21,732,567
   
21,949,233
   
21,699,233
 
                           
Effect of dilutive stock options and warrants
   
   
280,791
   
   
290,109
 
                           
Weighted average number
                         
of shares outstanding
                         
used in computing diluted
                         
net income (loss) per share
   
21,965,067
   
22,013,358
   
21,949,233
   
21,989,342
 
                           
Basic net income (loss) per share
 
$
(0.01
)
$
0.01
 
$
(0.01
)
$
0.00
 
                           
Diluted net income (loss) per share
 
$
(0.01
)
$
0.01
 
$
(0.01
)
$
0.00
 

In May 2005, the Company issued 22,500 shares of restricted common stock under its 2002 Equity Incentive Plan to its non-employee directors in exchange for their service on the board of directors and its various committees during 2005 with such shares to vest quarterly throughout this year. The Company’s board of directors reserved the right to reevaluate this form of director compensation and each director has the right to reevaluate the choice of restricted shares or cash for service as a director in 2006. Additionally, the Company issued 10,000 restricted common shares as a one-time new director grant for a new non-employee director, and it issued 15,000 restricted common shares as annual grants to two non-employee directors (7,500 shares to each director). These one-time and annual grants vest annually over a three-year period.
 
Deferred compensation equivalent to the market value of these shares at date of issuance is reflected in Shareholders’ Equity and is being amortized to operating expense over the applicable vesting period. Deferred compensation expense included in the accompanying condensed consolidated statements of operations amounted to $20,000 and $8,000 for the three month periods ended June 30, 2005 and 2004, respectively, and $35,000 and $17,000 for the and six month periods ended June 30, 2005 and 2004, respectively.

4. Cash and Cash Equivalents
 
The Company considers all non-restrictive, highly liquid short-term investments purchased with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents, which are stated at cost amount to approximately $1.2 million and approximately $1.9 million at June 30, 2005 and December 31, 2004, respectively, consist principally of interest-bearing cash deposits placed with various financial institutions.
 
5. Trade Accounts Receivable 
 
Trade accounts receivable comprised the following:
 

  
-10-



   
June 30,
 
December 31,
 
   
2005
 
2004
 
Healthcare:
         
Trade accounts receivable
 
$
3,962,000
 
$
4,319,000
 
Less - allowance for doubtful accounts
   
(493,000
)
 
(380,000
)
     
3,469,000
   
3,939,000
 
Real Estate Advisory Services:
             
Trade accounts receivable
   
1,819,000
   
2,411,000
 
Less - allowance for doubtful accounts
   
-
   
-
 
     
1,819,000
   
2,411,000
 
               
   
$
5,288,000
 
$
6,350,000
 


 
Healthcare trade accounts receivable consists primarily of amounts receivable from third-party payers (insurance companies and governmental agencies) under various medical reimbursement programs, institutional healthcare providers, individuals and others and are not collateralized. Certain receivables are recorded at estimated net realizable amounts. Amounts that may be received under medical reimbursement programs are affected by changes in payment criteria and are subject to legislative actions. The Company’s Healthcare segment reduces its accounts receivable by an allowance for the amounts deemed to be uncollectible. In general, an allowance for retail pharmacy accounts aged in excess of 60 days and infusion therapy accounts aged in excess of 180 days is established. Accounts that management has ultimately determined to be uncollectible are written off against the allowance.

Healthcare accounts receivable from Medicare and Medicaid combined were approximately 19.8% and 18.4% of total accounts receivable at June 30, 2005 and December 31, 2004, respectively. The Company’s Healthcare segment also had receivables in excess of 10% of accounts receivable from three major insurance companies representing 34.3% and 15.3% of total accounts receivable at June 30, 2005 and December 31, 2004, respectively. No other single customer or third-party payer accounted for more than 10% of accounts receivable at June 30, 2005 or December 31, 2004, respectively.

The Company’s real estate advisory services segment grants credit to customers of various sizes and provides an allowance for doubtful accounts equal to the estimated uncollectible amounts based on historical collection experience and a review of the current status of trade accounts receivable. The Company’s real estate advisory services segment derived revenues in excess of ten percent from two customers combined totaling approximately $1,340,000, or 50.2% of revenues for the three month period ended June 30, 2005 and revenues from one customer in excess of 10% totaling approximately $2,166,000 or 35.4% of revenues for the six month period ended June 30, 2005, respectively.

6. Inventories

Inventories consist of the following:

   
June 30,
 
December 31,
 
   
2005
 
2004
 
Inventories-retail pharmacy
 
$
1,624,000
 
$
1,498,000
 
Inventories-infusion/homecare
   
442,000
   
480,000
 
Inventories-general retail
   
549,000
   
578,000
 
Less: Inventory reserves
   
(95,000
)
 
(58,000
)
   
$
2,520,000
 
$
2,498,000
 

7. Prepaid Expenses
 
Prepaid expenses comprised the following:
 

  
-11-



   
June 30,
 
December 31,
 
   
2005
 
2004
 
           
Prepaid insurance
 
$
259,000
 
$
279,000
 
Deferred tenant representation costs
   
99,000
   
200,000
 
Prepaid marketing costs
   
78,000
   
-
 
Prepaid rent
   
148,000
   
-
 
Other prepaid expenses
   
38,000
   
24,000
 
   
$
622,000
 
$
503,000
 

 
The Company’s real estate advisory services segment defers direct costs associated with its tenant representation services until such time a lease is signed between the tenant and landlord. Upon execution of a signed lease, the Company expenses 50% of these direct costs associated with the transactions, with the balance being paid by the individual broker through a reduction in the commission earned. The Company regularly reviews these direct costs and expenses such costs related to canceled or unlikely to be completed transactions.
  
8. Property and Equipment
 
Property and equipment comprised the following:
 
   
Estimated
 
June 30,
 
December 31,
 
   
Useful Lives
 
2005
 
2004
 
               
Computer equipment and software
   
3 to 5 years
 
$
465,000
 
$
317,000
 
Furniture, fixtures and equipment
   
5 to 7 years
   
395,000
   
336,000
 
Leasehold improvements
   
Life of Lease
   
567,000
   
321,000
 
           
1,427,000
   
974,000
 
Less accumulated depreciation and amortization
 
(412,000
)
 
(258,000
)
         
$
1,015,000
 
$
716,000
 

The Company provides for depreciation based on the estimated useful lives of depreciable assets using the straight-line method. Depreciation expense was $82,000 and $65,000 for the three month periods ended June 30, 2005 and 2004, respectively, and $156,000 and $71,000 for the six month periods ended June 30, 2005 and 2004, respectively.
 
9. Goodwill and Other Intangibles
 
Goodwill and other intangible assets comprised the following:
 
   
June 30,
 
December 31,
 
   
2005
 
2004
 
           
Goodwill
 
$
7,299,000
 
$
7,299,000
 
Other intangible assets:
             
Patient Prescriptions
   
544,000
   
544,000
 
Non-compete Agreements
   
450,000
   
450,000
 
Less - accumulated amortization
   
(402,000
)
 
(236,000
)
   
$
592,000
 
$
758,000
 

The excess of the purchase price over the net tangible assets acquired have been allocated to (i) patient prescriptions for the Park Assets acquisition in 2004, and (ii) non-compete agreements and goodwill for the CPOC acquisition in 2004. In connection with the CPOC acquisition, the Company obtained non-compete agreements from nine of CPOC’s management and key employees, including Kevin Hayes, CPOC’s Chairman. The non-compete agreements are being amortized over their contractual life of 3 years, which amounted to $37,500 and $75,000 for the three and six month periods ended June 30, 2005, respectively.
  
-12-


The Company amortizes its patient prescriptions acquired in the acquisition of the Park Assets over 3 years, which amounted to $45,000 and $90,000 for the three and six month periods ended June 30, 2005, respectively.

10. Investments in Limited Partnerships
 
Investments in limited partnerships comprised the following: 

   
Ownership
 
June 30,
 
December 31,
 
 
%
 
2005
 
2004
 
               
Ampco Partners, Ltd.
   
10%
 
$
237,000
 
$
256,000
 
Fairways 03 New Jersey, LP
   
20%
 
 
220,000
   
-
 
Fairways Frisco, L.P.
   
14%
 
 
1,000,000
   
154,000
 
         
$
1,457,000
 
$
410,000
 

On January 7, 2005, the Company filed a Current Report on Form 8-K (the “Initial Report”) to report the Company’s acquisition on December 31, 2004 of certain indirect interests in various partnerships (the “Frisco Square Partnerships”) that own properties (“Properties”) in the 150-acre Frisco Square mixed-use real estate development in Frisco, Texas, pursuant to that certain Master Agreement Regarding Frisco Square Partnerships, dated December 31, 2004 (the “Master Agreement”), all as described in the Initial Report. Additional information about this transaction was provided in Current Reports on Form 8-K filed on January 14, 2005 (the “January Report”) and February 23, 2005 (the “February Report”). On March 16, 2005, the Company filed Amendment No. 1 to the Initial Report (the “March Report”) to amend Item 1.01 of the January Report and the February Report to update the status of the capital contributions to Fairways Frisco, L.P., a Texas limited partnership (“Fairways Frisco”), and Item 9.01 of the Initial Report to update the status of the financial statements and pro forma financial information required under Item 9.01 of Form 8-K. On April 29, 2005, the Company filed Amendment No. 2 to the Initial Report to amend Item 1.01 of the January Report and the February Report to update the status of the Master Agreement entered into on December 31, 2004, update the status of capital contributions to Fairways Frisco, L.P. and to disclose certain other events related to Fairways Frisco and the Frisco Square Partnerships.

As described in the Company’s Current Report on Form 8-K filed January 14, 2005, the Company entered into an oral agreement with Fairways Equities, LLC, a Texas limited liability company (“FEL”), to co-invest with FEL in the Partnerships. FEL has 4 members who each own 25% of its membership interests, James C. Leslie, the Chairman and principal shareholder of the Company, and Cathy Sweeney, Brant Bryan and David Stringfield, who are each shareholders of the Company as well as employees of CRESA Capital Markets Group, LP, a subsidiary of the Company (the “Fairways Members”).

On April 15, 2005, the parties to the Master Agreement agreed to terminate the Master Agreement effective as of April 15, 2005. In connection with the termination of the Master Agreement, the Frisco Square Partnerships were amended such that Fairways Frisco owns, either directly or indirectly, 60% of the Frisco Square Partnerships. The remaining 40% is owned by CMP Family Limited Partnership (“CMP”), which is controlled by Cole McDowell. CMP’s partnership interest is subject to further reduction and dilution as discussed below. Under the terms of the amended Frisco Square Partnerships, Fairways Frisco also has a first priority distribution preference of $5.5 million, and it will receive its pro-rata partnership interest of the next $9.5 million of distributions from the Frisco Square Partnerships. After $15 million of distributions have been made, Fairways Frisco’s interest in the Frisco Square Partnerships will become 80% and CMP’s interest will become 20%. Furthermore, Fairways Frisco’s partnership interest in the Frisco Square Partnerships may be increased up to 90% if certain capital call and limited partner capital loan provisions are not met by CMP. If Fairways Frisco’s partnership interest in the Frisco Square Partnerships is increased in the future, the Company’s indirect interest in the Frisco Square Partnerships would also increase on a pro-rata basis with its investment in Fairways Frisco.

  
-13-



Under the terms of the amended Frisco Square Partnerships agreements, FEL is now the sole general partner of the Frisco Square Partnerships and controls all operating activities, financing activities and development activities for the Frisco Square Partnerships.

Also on April 15, 2005, Fairways Frisco, through Frisco Square Land, Ltd., a newly created partnership, closed a financing transaction, the proceeds of which were used to repay the outstanding bank debt of Frisco Square, Ltd and to provide additional working capital for Fairways Frisco. Under the terms of the now terminated Master Agreement, Fairways Frisco held an option to acquire 50% of the partnership interests of Frisco Square, Ltd. Concurrently with the financing, all of the land and related development held by Frisco Square, Ltd. was transferred to Frisco Square Land, Ltd. in exchange for repayment of the bank debt, and the option to acquire 50% of the partnership interests of Frisco Square, Ltd. was cancelled. As a result of these changes, Fairways Frisco now has no interest in Frisco Square, Ltd. Fairways Frisco owns 60% of Frisco Square Land, Ltd., subject to the same increases for preference distributions and dilution to CMP if certain capital call and limited partner capital loan provisions are not met by CMP as discussed above.

The Company has not guaranteed any of the debt of the Frisco Square Partnerships or Fairways Frisco, L.P.. The Company is not involved with any management, financing or other operating activities of the Frisco Square Partnerships or Fairways Frisco. However, in May 2005, the Company entered into an agreement with FEL, pursuant to which the Company is entitled to receive 25% of the fees paid to FEL pursuant to the Fairways Frisco partnership agreement. These fees, including a monthly management fee, represent compensation to the Company for supplying resources to execute the initial transaction with the Frisco Square Partnerships in December 2004. The Company received $35,000 in April 2005, representing its 25% share of certain fees paid to FEL pursuant to the April 15, 2005 financing transaction described above. As of June 30, 2005, the Company has not received an allocation of any monthly management fees from FEL under the agreement.

As of June 30, 2005, the Company has made aggregate capital contributions of $1.0 million to Fairways Frisco, L.P.. As of June 30, 2005, Fairways Frisco, L.P. has received aggregate capital contributions of $6.9 million. The Company has made no additional capital contributions subsequent to June 30, 2005.  However, Fairways Frisco, L.P. has received additional capital contributions from other limited partners of $600,000 subsequent to June 30, 2005 and it is expected to request additional capital contributions from the limited partners.  The Company does not expect to fund any additional capital requested from Fairways Frisco, L.P. As a result, the Company’s $1.0 million investment has been reduced to 13.7% of the limited partnership interests of Fairways Frisco and 8.2% (subject to adjustment as described above) of the limited partnership interests of the Frisco Square Partnerships (indirectly through Fairways Frisco). The Company expects its limited partnership interest will be reduced further as additional limited partner contributions are received and the Company does not fund its limited partnership share of such capital contributions into Fairways Frisco, L.P.

In the March Report, the Company reported that the independent auditors for the Frisco Square Partnerships had not yet completed their audits of the financial statements for the years ended December 31, 2004 and 2003. Subsequently, the Company has determined that based on the size of its investment in the Frisco Square Partnerships, it is not required to file audited financial statements for the Frisco Square Partnerships. The Company owns, indirectly through its limited partnership interest in Fairways Frisco, less than 10% of the Frisco Square Partnerships. The Frisco Square Partnerships will require additional funding from Fairways Frisco in order to continue development of its real estate. However, the Company is not obligated to invest any additional funds if Fairways Frisco makes a capital call for additional cash, although it may choose to do so depending on its available funds. The Company expects its ownership percentage in Fairways Frisco will decline further if additional capital calls are received for Fairways Frisco’s funding needs and the Company does not fund its pro-rata share of such funding needs. Based on these factors, the Company intends to account for its investment under the cost method of accounting and it does not believe that presenting separate audited financial statements of the Frisco Square Partnerships is meaningful or representative of its relationship with the Frisco Square Partnerships.

  
-14-



A detailed description of the Company’s investment in Fairways Frisco and the Frisco Square Partnerships (prior to the events described in this Note 10) is included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2004.

11. Accrued Expenses
 
Accrued expenses comprised the following:
 

 
 
June 30,
 
December 31,
 
   
2005
 
2004
 
           
Accrued real estate commissions & fees
 
$
1,915,000
 
$
2,060,000
 
Accrued payroll and related
   
396,000
   
540,000
 
Accrued other
   
89,000
   
220,000
 
Accrued rent
   
129,000
   
116,000
 
Accrued property, franchise and sales taxes
   
84,000
   
44,000
 
Accrued state income taxes payable
   
(10,000
)
 
181,000
 
   
$
2,603,000
 
$
3,161,000
 

12. Notes Payable
 
Notes payable comprised the following:
  
   
June 30,
 
December 31,
 
   
2005
 
2004
 
Bank of Texas Credit Facility, secured by substantially all healthcare assets
         
Term note A in the principal amount of $1,000,000, interest at 6% per annum payable monthly, principal due in full in March 2007.
 
$
528,000
 
$
688,000
 
               
Term note B in the principal amount of $4,000,000, interest at 6% per annum, principal and interest payable in monthly installments of $44,408 over 35 months with a balloon payment of principal of $3,084,000 due in March 2007.
   
3,630,000
   
3,783,000
 
               
Term note C in the principal amount of $529,539, interest at 6% per annum, principal and interest payable in monthly installments of $5,579 over 35 months with a balloon payment of principal of $408,000 due in March 2007.
   
480,000
   
501,000
 
               
AmerisourceBergen Drug Corporation, unsecured note payable
             
Unsecured note in the principal amount of $750,000, interest at 6% per annum, principal and interest payable in monthly installments of $6,329 over 59 months with a balloon payment of principal of $576,000 due in March 2009.
   
710,000
   
726,000
 
               
Note payable Kevin Hayes, prior shareholder of CRESA Partners of Orange County, Inc. (predecessor to CRESA Partners of Orange County, LP, f/k/a The Staubach Company - West, Inc.)
             
Acquisition note in the principal amount of $6,900,000 due May 1, 2007, interest at Northern Trust Bank prime rate plus 0.5% (6.25% at June 30, 2005) payable monthly, principal payable quarterly from the Company's equity interest in the operating cash flow, as defined, of CRESA Partners of Orange County, LP. secured by subordinated security interest in substantially all assets of CRESA Partners of Orange County, LP.
   
6,900,000
   
6,900,000
 
               
Capital lease obligations, secured by office equipment
   
11,000
   
18,000
 
               
Comerica Bank term note payable
             
Term note payable in the principal amount of $30,000, payable in 36 equal installments of $928 through April 2008, interest payable at the fixed rate of 7%, secured by all property and equipment of Ascendant Solutions, Inc.
   
29,000
   
-
 
     
12,288,000
   
12,616,000
 
Less current portion
   
(481,000
)
 
(461,000
)
   
$
11,807,000
 
$
12,155,000
 

The aggregate maturities of notes payable for the 12 months ended June 30 are as follows:
 
       
2006
 
$
481,000
 
2007
   
11,219,000
 
2008
   
47,000
 
2009
   
541,000
 
Thereafter
   
-
 
   
$
12,288,000
 

  13. Commitments and Contingencies
 
The Company leases its healthcare, real estate advisory services and corporate offices and certain pharmacy equipment under non-cancelable operating lease agreements. Certain leases contain renewal options and provide that the Company pay taxes, insurance, maintenance and other operating expenses. Total rent expense for operating leases was approximately $336,000 and $670,000 for the three and six month periods ended June 30, 2005, respectively.
 
Future minimum lease payments under non-cancelable operating leases for the twelve months ending June 30 are as follows:

 
     
2006
 
$
1,543,000
 
2007
   
1,296,000
 
2008
   
1,008,000
 
2009
   
828,000
 
2010
   
630,000
 
Thereafter
   
260,000
 
   
$
5,565,000
 
 
In January 2005, the Company agreed to indemnify the other partners of Fairways 03 New Jersey, LP (who are also the Fairways Members) for its 20% pro rata partnership interest of a guarantee of bank indebtedness which the partners provided to a bank. The Company estimated its obligation under this indemnification to be $220,000 and recorded this amount as a contingent liability and an increase to its investment in limited partnerships. At the present time, the Company does not believe it is probable that any defaults will occur on the bank debt subject to this guaranty and indemnification. The Company’s maximum liability, if any, under this limited indemnification is $520,000.

14. Subsequent Events

In July 2005, the single tenant commercial real estate property indirectly and partially owned by Fairways 03 New Jersey, LP was put under an option agreement to be sold. If the potential buyer exercises the purchase option, the property is expected to be sold in December 2005. In connection with the execution of the option agreement, Fairways 03 New Jersey, LP received a non-refundable option payment.

  
-17-


This option payment was distributed to the limited partners on a pro-rata basis with their limited partnership interests. The Company received $66,500 as its pro rata share of this option payment, and this amount was recorded as a reduction of its investment in Fairways 03 New Jersey, LP. The proceeds from sale, if the purchase option is exercised by the buyer, would be used to pay off the $2.6 million in bank debt and the Company would have no further obligation under the indemnification agreement described in Note 13.

15. Related Party Transactions

During the three months ended June 30, 2005, CRESA Capital Markets Group, LP, a subsidiary of the Company received approximately $88,000 in cash advances from the Fairways Members that were used to pay general operating expenses. These non-interest bearing advances are expected to be repaid only upon the receipt of revenues from capital markets real estate advisory transactions expected to close later in 2005. Subsequent to June 30, 2005 and through August 1, 2005, the Fairways Members made additional cash advances of $20,000 to CRESA Capital Markets Group, LP to fund its operating expenses.

16. Business Segment Information
 
The Company is organized in three segments: (i) healthcare, (ii) real estate advisory services and (iii) corporate and other businesses. The healthcare segment consists of the operations of DHI and the real estate advisory services segment consists of the operations of the CRESA Partners of Orange County LP and CRESA Capital Markets Group LP. Key measures used by the Company’s management to evaluate business segment performance include revenue, cost of sales, gross profit, investment income and EBITDA. EBITDA is calculated as net income before deducting interest, taxes, depreciation and amortization. Although EBITDA is not a measure of actual cash flow because it does not consider changes in assets and liabilities that may impact cash balances, the Company believes it is a useful metric to evaluate operating performance.

Condensed statements of operations and balance sheet data for the Company’s principal business segments for the three and six month periods ended June 30, 2005 and 2004 are as follows (000’s omitted):

  
-18-




   
Three Months Ended June 30,
 
                                   
   
Healthcare
 
Real Estate Services
 
Corporate and Other
 
Consolidated
 
   
2005
 
2004
 
2005
 
2004
 
2005
 
2004
 
2005
 
2004
 
                                   
Revenue
 
$
9,892
 
$
9,895
 
$
2,684
 
$
2,390
 
$
-
 
$
-
 
$
12,576
 
$
12,285
 
Cost of sales
   
6,674
   
6,435
   
1,783
   
1,314
   
-
   
-
   
8,457
   
7,749
 
Gross profit
   
3,218
   
3,460
   
901
   
1,076
   
-
   
-
   
4,119
   
4,536
 
Investment income
   
1
   
-
   
-
   
-
   
116
   
70
   
117
   
70
 
Net Income (Loss)
   
($76
)
$
25
 
$
6
 
$
439
   
($154
)
 
($250
)
 
($224
)
$
214
 
                                                   
EBITDA
 
$
93
 
$
193
 
$
210
 
$
568
 
$
(156
)
$
(253
)
$
147
 
$
508
 
Less:
                                                 
Interest (Expense) Income
   
(84
)
 
(102
)
 
(110
)
 
(65
)
 
5
   
5
   
(189
)
 
(162
)
Taxes
   
-
   
-
   
(17
)
 
(48
)
 
-
   
-
   
(17
)
 
(48
)
Depreciation &
                                                 
Amortization
   
(85
)
 
(66
)
 
(77
)
 
(16
)
 
(3
)
 
(2
)
 
(165
)
 
(84
)
Net Income (Loss)
 
$
(76
)
$
25
 
$
6
 
$
439
 
$
(154
)
$
(250
)
$
(224
)
$
214
 
                                                   

   
Six Months Ended June 30,
 
                                   
   
Healthcare
 
Real Estate Services
 
Corporate and Other
 
Consolidated
 
   
2005
 
2004
 
2005
 
2004
 
2005
 
2004
 
2005
 
2004
 
                                   
Revenue
 
$
19,717
 
$
10,670
 
$
6,128
 
$
3,067
 
$
-
 
$
-
 
$
25,845
 
$
13,737
 
Cost of sales
   
13,326
   
6,942
   
3,832
   
1,521
   
-
   
-
   
17,158
   
8,463
 
Gross profit
   
6,391
   
3,728
   
2,296
   
1,546
   
-
   
-
   
8,687
   
5,274
 
Investment income
   
4
   
-
   
-
   
-
   
190
   
140
   
194
   
140
 
Net Income (Loss)
 
$
(205
)
$
40
 
$
459
 
$
580
 
$
(402
)
$
(512
)
$
(148
)
$
108
 
                                                   
EBITDA
 
$
135
 
$
218
 
$
892
 
$
711
 
$
(409
)
$
(518
)
$
618
 
$
411
 
Less:
                                                 
Interest (Expense) Income
   
(169
)
 
(109
)
 
(210
)
 
(65
)
 
12
   
9
   
(367
)
 
(165
)
Taxes
   
-
   
-
   
(77
)
 
(48
)
 
-
   
-
   
(77
)
 
(48
)
Depreciation &
                                                 
Amortization
   
(171
)
 
(69
)
 
(146
)
 
(18
)
 
(5
)
 
(3
)
 
(322
)
 
(90
)
Net Income (Loss)
 
$
(205
)
$
40
 
$
459
 
$
580
 
$
(402
)
$
(512
)
$
(148
)
$
108
 
                                                   

   
June 30,
 
   
Healthcare
 
Real Estate Services
 
Corporate and Other
 
Consolidated
 
   
2005
 
2004
 
2005
 
2004
 
2005
 
2004
 
2005
 
2004
 
                                   
Total assets
 
$
8,105
 
$
9,914
 
$
11,277
 
$
11,571
 
$
1,056
 
$
1,107
 
$
20,438
 
$
22,592
 


  
-19-


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and notes thereto included elsewhere in this report together with the consolidated financial statements, notes and management’s discussion contained in our Form 10-K for the year ended December 31, 2004.
 
Except for the historical information contained herein, the discussion in this report contains certain forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. Our forward-looking statements are based on the current expectations of management, and we assume no obligation to update this information. The cautionary statements made in this report should be read as being applicable to all related forward-looking statements, wherever they appear in this report. Furthermore, see the Company’s most recent Form 10-K for the year ended December 31, 2004, including the section titled “Risks Related to Our Business,”“Risks Specific to Operating Subsidiaries,”“Risks Related to Our Investments in Real Estate,” and “Other Risks.” These risks, uncertainties and other factors include, but are not limited to: limited funding and the difficulty of finding additional financing, if necessary; dependence on management; dependence on our small staff; the potential for a subsidiary to account for a significant percentage of our revenue; unforeseen acquisition costs; potential asset impairment charges; pending litigation; potential for future leveraged transactions; restrictions on use of net operating loss carryforwards; highly leveraged subsidiaries; inability to integrate and manage operating subsidiaries; pharmacy regulations; competition in the pharmacy industry; concentration of ownership and control; related party transactions; our stock has been delisted from The NASDAQ National Market; the success of real estate developments is dependent on tenants to generate lease revenues; the uncertainty inherent in real estate development; and illiquidity of real estate and reinvestment risk may reduce economic returns to investors.
 
In addition to the aforementioned risk factors, our future operating results are difficult to predict. Factors that are likely to cause varying results include our ability to profitably operate DHI and CPOC and to pay the principal and interest on the significant debt incurred to make these acquisition; our success with the investments in, and operations of Ampco, Capital Markets and our participation in Fairways transactions; the results of our investments in real estate; fluctuations in general interest rates; the availability and cost of capital to us; the existence and amount of unforeseen acquisition costs; and our ability to locate and successfully acquire or develop one or more business enterprises.
 
The Company
 
Ascendant Solutions, Inc. (“we,”“us,” or “our Company”) is a Delaware corporation with principal executive offices located at 16250 Dallas Parkway, Suite 205, Dallas, Texas 75248 (telephone number 972-250-0945). We are a diversified financial services company which is seeking to, or has invested in, or acquired, healthcare, manufacturing, distribution or service companies. We are organized in three segments: (i) healthcare, (ii) real estate advisory services and (iii) corporate and other businesses. A detailed discussion of our business segments is included in our Form 10-K for the year ended December 31, 2004.
 
Healthcare
 
Our healthcare segment consists of Dougherty’s Holdings, Inc. (“DHI”), which operates specialty retail pharmacies and infusion therapy/specialty pharmacy services units. Based in Dallas, Texas, DHI operates (i) Dougherty’s Pharmacy Inc. in Dallas, a specialty compounding pharmacy, (ii) three specialty pharmacies in the area between Houston and the Gulf of Mexico coast under the name “Medicine Man,” and (iii) three infusion therapy facilities in Dallas, San Antonio and Houston, Texas under the name “Park InfusionCare.”
 
Real Estate Advisory Services
 
Our real estate advisory services segment consists of (i) CRESA Capital Markets Group, L.P. a subsidiary 80% owned by us (ii) our wholly owned subsidiary ASDS of Orange County, Inc., a Delaware corporation f/k/a Orange County Acquisition Corp. (“ASDS”) and (iii) our 99% owned subsidiary CRESA Partners of Orange County, LP. (“CPOC”).

  
-20-



Revenue is recognized by our real estate advisory services segment generally upon execution of a lease contract and performance of any required services under the contract. As such, our real estate advisory services revenue stream is subject to variability from period to period based upon the timing of lease contract executions. Comparison of revenues and related cost of sales from period to period may not be indicative of the current or future performance of the underlying business.

  Corporate & Other Businesses
 
Our corporate & other businesses segment includes investments in and results from investments in unconsolidated subsidiaries. The investments and investment results included in this segment are from the following entities: Ampco Partners, Ltd., Fairways Frisco, LP and Fairways Equities LLC.

Key measures used by the Company’s management to evaluate business segment performance include revenue, cost of sales, gross profit, investment income and EBITDA. EBITDA is calculated as net income before deducting interest, taxes, depreciation and amortization. Although EBITDA is not a measure of actual cash flow because it does not consider changes in assets and liabilities that may impact cash balances, the Company believes it is a useful metric to evaluate operating performance and has therefore included such measures in the discussion of operating results below.

  
-21-


 Results of Operations

 Comparison of the Three Months Ended June 30, 2005 to the Three Months Ended June 30, 2004
 

   
Three Months Ended June 30,
 
                           
   
Healthcare
 
Real Estate Advisory Services
 
           
Dollar
         
Dollar
 
   
2005
 
2004
 
Change
 
2005
 
2004
 
Change
 
                           
Revenue
 
$
9,892
 
$
9,895
 
$
(3
)
$
2,684
 
$
2,390
 
$
294
 
Cost of Sales
   
6,674
   
6,435
   
239
   
1,783
   
1,314
   
469
 
Gross Profit
   
3,218
   
3,460
   
(242
)
 
901
   
1,076
   
(175
)
Operating expenses
   
3,211
   
3,331
   
(120
)
 
785
   
509
   
276
 
Investment income
   
1
   
-
   
1
   
-
   
-
   
-
 
Interest income (expense), net
   
(84
)
 
(102
)
 
18
   
(110
)
 
(65
)
 
(45
)
Gain (loss) on sale of equipment
   
-
   
(2
)
 
2
   
-
   
(15
)
 
15
 
Limited partnership and minority interests
   
-
   
-
   
-
   
17
   
-
   
17
 
State income tax provision
   
-
   
-
   
-
   
(17
)
 
(48
)
 
31
 
Net income (loss)
 
$
(76
)
$
25
 
$
(101
)
$
6
 
$
439
 
$
(433
)
Plus:
                                     
Interest (income) expense, net
 
$
84
 
$
102
 
$
(18
)
$
110
 
$
65
 
$
45
 
State income tax provision
   
-
   
-
   
-
   
17
   
48
   
(31
)
Depreciation & Amortization
   
85
   
66
   
19
   
77
   
16
   
61
 
Earnings Before Interest, Taxes,
                                     
Depreciation & Amortization
 
$
93
 
$
193
 
$
(100
)
$
210
 
$
568
 
$
(358
)
                                       

   
Corporate & Other
 
Consolidated
 
           
Dollar
         
Dollar
 
   
2005
 
2004
 
Change
 
2005
 
2004
 
Change
 
                           
Revenue
 
$
-
 
$
-
 
$
-
 
$
12,576
 
$
12,285
 
$
291
 
Cost of Sales
   
-
   
-
   
-
   
8,457
   
7,749
   
708
 
Gross Profit
   
-
   
-
   
-
   
4,119
   
4,536
   
(417
)
Operating expenses
   
275
   
326
   
(51
)
 
4,271
   
4,166
   
105
 
Investment income
   
116
   
70
   
46
   
117
   
70
   
47
 
Interest income (expense), net
   
5
   
5
   
-
   
(189
)
 
(162
)
 
(27
)
Gain (loss) on sale of equipment
   
-
   
-
   
-
   
-
   
(17
)
 
17
 
Limited partnership and minority interests
   
-
   
1
   
(1
)
 
17
   
1
   
16
 
State income tax provision
   
-
   
-
   
-
   
(17
)
 
(48
)
 
31
 
Net income (loss)
 
$
(154
)
$
(250
)
$
96
 
$
(224
)
$
214
 
$
(438
)
Plus:
                                     
Interest (income) expense, net
   
($5
)
 
($5
)
$
0
 
$
189
 
$
162
 
$
27
 
State income tax provision
   
-
   
-
   
-
   
17
   
48
   
(31
)
Depreciation & Amortization
   
3
   
2
   
1
   
165
   
84
   
81
 
Earnings Before Interest, Taxes,
                                     
Depreciation & Amortization
 
$
(156
)
$
(253
)
$
97
 
$
147
 
$
508
 
$
(361
)

  
-22-


Healthcare

Revenue
Total revenue decreased $3,000 during the second quarter of 2005 to $9,892,000. The change in revenue is comprised of (i) a decrease of $327,000 in revenue from infusion services due to increased competition, and (ii) an increase of $324,000 in revenue from retail pharmacies as a result of increased drug pricing and increased marketing efforts.

Cost of sales/Gross profit
The cost of sales increased $239,000, or 2.4% of revenue during the second quarter of 2005 to $6,674,000. The increase is primarily attributable to increased revenue at the retail pharmacies and an increase in inventory shrinkage at the retail pharmacies. This increase is offset by a decrease in cost of sales from infusion services attributable to decreased sales volume from infusion services.

Gross profit decreased $242,000, or 2.5% of revenue. Gross profit was 32.5% of revenue in the second quarter of 2005 as compared to 35.0% for the second quarter of 2004. The reason for the decrease in the gross profit percentage is due to a decline of 4% in the gross profit percentage from infusion services as a result of a change in the revenue mix toward lower margin therapies, combined with a decrease of 1% in the gross profit percentage at the retail pharmacies as a result of increased inventory shrinkage.

Operating expenses
Operating expenses decreased $120,000 from $3,331,000 in the second quarter of 2004 to $3,211,000 in the second quarter of 2005. The decrease in healthcare operating expenses includes (i) a decrease of $72,000 due to reduced headcount at various locations, (ii) a decrease of $146,000 in bad debt expense from the collection of previously written off accounts receivable, and (iii) an increase of $77,000 in professional fees for audit, accounting and legal services.

 Depreciation and amortization
Depreciation and amortization expense increased $19,000 from $66,000 in the second quarter of 2004 to $85,000 in the second quarter of 2005, which includes $45,000 of amortization of patient prescriptions which were recorded as an intangible asset acquired in the acquisition of the Park Assets. This intangible asset is being amortized over 3 years. The comparable amortization expense recorded in the second quarter of 2004 was $19,000. The increase in amortization results from adjustments to increase the purchase price of the Park assets by $311,000 during the third and fourth quarters of 2004 for acquisition costs and adjustments to the fair value of receivables at the acquisition date.

Interest expense, net
Net interest expense was $84,000 for the second quarter of 2005 compared to net interest expense of $102,000 for the second quarter of 2004. The decrease in net interest expense is due to a decrease in the outstanding notes payable balances due to Bank of Texas and AmerisourceBergen.

 Real Estate Advisory Services

Revenue
Revenue increased $294,000 from $2,390,000 in the second quarter of 2004 to $2,684,000 during the second quarter of 2005. The revenue for the second quarter of 2004 included fee revenue of $5,000 earned by CRESA Capital Markets, compared to corresponding fee revenue of $17,000 in the second quarter of 2005. The remaining $2,385,000 of real estate advisory services revenue in the second quarter of 2004 represented fee revenue earned by CPOC for the period from the date of acquisition on May 1, 2004 through June 30, 2004. CPOC earned fee revenue of $2,667,000 during the second quarter of 2005.

Cost of Sales/Gross profit
Cost of sales was $1,783,000 for the second quarter of 2005, representing 66.4% of revenue, compared to $1,314,000 or 55.0% of revenues for the second quarter of 2004. Cost of revenue includes all direct costs, including broker commissions, incurred in connection with a real estate advisory transaction. The increase of $469,000 in cost of sales over the second quarter of 2004 is due primarily to the inclusion of CPOC’s cost of sales for a full quarter in 2005, as compared to only two months in the second quarter of 2004.

  
-23-


CPOC was acquired by the Company on May 1, 2004. The increase of 11.4% in cost of sales as a percentage of revenue is due mostly to an increase in the percentage commission paid to brokers after the broker reaches a cumulative targeted revenue level.

Operating Expenses
Operating expenses increased $276,000 from $509,000 in the second quarter of 2004 to $785,000 for the second quarter of 2005. This increase includes an increase of $18,000 in selling, general and administrative expenses at Capital Markets due mostly to an increase in professional headcount. The increase in operating expenses also includes an increase of $258,000 in the second quarter of 2005 as compared to the second quarter of 2004 due to the inclusion of CPOC’s selling, general and administrative expenses and depreciation and amortization of $75,000 for a full quarter in 2005, as compared to only two months in the second quarter of 2004. CPOC was acquired by the Company on May 1, 2004.

Depreciation and amortization
Depreciation and amortization expense increased $61,000 in the second quarter of 2005 as compared to the second quarter of 2004. The increase is due to the inclusion of the results of operations of CPOC for a full quarter in 2005, as compared to only two months in the second quarter of 2004. CPOC was acquired by the Company on May 1, 2004. The increase also includes $37,500 of amortization of non-compete agreements which were recorded as an intangible asset in connection with the acquisition of CPOC on May 1, 2004, which are being amortized over their contractual life of 3 years. There was no comparable amortization expense recorded in the second quarter of 2004, as the Company did not complete its final allocation of the purchase price until the end of its 2004 fiscal year.

Interest expense, net
Interest expense, net is comprised of interest expense related to the debt assumed and incurred as part of the CPOC acquisition. Interest expense, net was $110,000 for the second quarter of 2005, based on the Northern Trust Bank prime rate plus 0.50% on the $6.9 million outstanding balance of the CPOC Acquisition Note. The Northern Trust Bank prime rate was 6.25% at June 30, 2005. Interest expense, net was $65,000 for the second quarter of 2004, and included interest expense incurred on the $6.9 million CPOC Acquisition Note, a $500,000 note payable to Kevin Hayes and a $500,000 line of credit payable to Northern Trust Bank. All of these notes payable bore interest at the Northern Trust Bank prime rate, which was 4.00% at June 30, 2004. The interest expense incurred on the Acquisition Note Payable to Kevin Hayes was $110,000 for the second quarter of 2005 as compared to $53,000 for the second quarter of 2004. The increase is also partially due to the inclusion of CPOC’s interest expense for a full three months in the quarter ending June 30, 2005, as compared to only two months for the quarter ending June 30, 2004. CPOC was acquired by the Company on May 1, 2004.

State income tax expense
The state income tax expense was $17,000 in the second quarter of 2005 as compared to $48,000 in the second quarter of 2004. The pretax earnings of CPOC for purposes of calculating California state income tax expense was $103,000 in the second quarter of 2005 as compared to $517,000 for the second quarter of 2004. The Company’s net operating loss carryforwards for Federal and state income tax purposes does not contain any loss carryforwards available to offset California state income taxes.

Corporate & Other

Operating expenses
Operating expenses decreased $51,000 from $326,000 in the second quarter of 2004 to $275,000 in the second quarter of 2005. The decrease is primarily comprised of : (i) an increase in selling, general and administrative expenses of $37,500 due to increased payroll from one additional professional staff in the second quarter of 2005, (ii) a decrease in accounting, legal and other professional fees of $103,000 as a result of fees related to two acquisitions in 2004, and (iii) an increase of $11,000 in amortization of deferred compensation in the second quarter of 2005 resulting from the issuance of restricted stock to directors and officers.

 Investment income
Investment income was $116,000 in the second quarter of 2005 and included $45,000 of income from distributions received from the Company’s Fairways 03 New Jersey, LP investment compared to $55,000 for the second quarter of 2004. The Company received a distribution of $45,000 from Ampco for the second quarter of 2005, of which $36,000 was recorded as investment income representing the Company’s investment share of Ampco earnings and $9,000 was recorded as a reduction of the Company’s investment asset in Ampco.

  
-24-


In the second quarter of 2004, the Company received a distribution of $22,000 from Ampco, of which $15,000 was recorded as investment income representing the Company’s investment share of Ampco earnings and $7,000 was recorded as a reduction of the Company’s investment asset in Ampco. Additionally in the second quarter of 2005, the Company received $35,000 from FEL. under an agreement whereby the Company receives 25% of certain fees earned by FEL pursuant to the Fairways Frisco limited partnership agreement.

  
-25-


Comparison of the Six Months Ended June 30, 2005 to the Six Months Ended June 30, 2004


   
Six Months Ended June 30,
 
                           
   
Healthcare
 
Real Estate Advisory Services
 
           
Dollar
         
Dollar
 
   
2005
 
2004
 
Change
 
2005
 
2004
 
Change
 
                           
Revenue
 
$
19,717
 
$
10,670
 
$
9,047
 
$
6,128
 
$
3,067
 
$
3,061
 
Cost of Sales
   
13,326
   
6,942
   
6,384
   
3,832
   
1,521
   
2,311
 
Gross Profit
   
6,391
   
3,728
   
2,663
   
2,296
   
1,546
   
750
 
Operating expenses
   
6,431
   
3,577
   
2,854
   
1,578
   
804
   
774
 
Investment income
   
4
   
-
   
4
   
-
   
-
   
-
 
Interest income (expense), net
   
(169
)
 
(109
)
 
(60
)
 
(210
)
 
(65
)
 
(145
)
Gain (loss) on sale of equipment
   
-
   
(2
)
 
2
   
(1
)
 
(15
)
 
14
 
Limited partnership and minority interests
   
-
   
-
   
-
   
29
   
(34
)
 
63
 
State income tax provision
   
-
   
-
   
-
   
(77
)
 
(48
)
 
(29
)
Net income (loss)
 
$
(205
)
$
40
 
$
(245
)
$
459
 
$
580
 
$
(121
)
Plus:
                                     
Interest (income) expense, net
 
$
169
 
$
109
 
$
60
 
$
210
 
$
65
 
$
145
 
State income tax provision
   
-
   
-
   
-
   
77
   
48
   
29
 
Depreciation & Amortization
   
171
   
69
   
102
   
146
   
18
   
128
 
Earnings Before Interest, Taxes,
                                     
Depreciation & Amortization
 
$
135
 
$
218
 
$
(83
)
$
892
 
$
711
 
$
181
 
                                       

   
Corporate & Other
 
Consolidated
 
           
Dollar
         
Dollar
 
   
2005
 
2004
 
Change
 
2005
 
2004
 
Change
 
                           
Revenue
 
$
-
 
$
-
 
$
-
 
$
25,845
 
$
13,737
 
$
12,108
 
Cost of Sales
   
-
   
-
   
-
   
17,158
   
8,463
   
8,695
 
Gross Profit
   
-
   
-
   
-
   
8,687
   
5,274
   
3,413
 
Operating expenses
   
604
   
656
   
(52
)
 
8,613
   
5,037
   
3,576
 
Investment income
   
190
   
140
   
50
   
194
   
140
   
54
 
Interest income (expense), net
   
12
   
9
   
3
   
(367
)
 
(165
)
 
(202
)
Gain (loss) on sale of equipment
   
-
   
-
   
-
   
(1
)
 
(17
)
 
16
 
Limited partnership and minority interests
   
-
   
(5
)
 
5
   
29
   
(39
)
 
68
 
State income tax provision
   
-
   
-
   
-
   
(77
)
 
(48
)
 
(29
)
Net income (loss)
 
$
(402
)
$
(512
)
$
110
 
$
(148
)
$
108
 
$
(256
)
Plus:
                                     
Interest (income) expense, net
 
$
(12
)
$
(9
)
$
(3
)
$
367
 
$
165
 
$
202
 
State income tax provision
   
-
   
-
   
-
   
77
   
48
   
29
 
Depreciation & Amortization
   
5
   
3
   
2
   
322
   
90
   
232
 
Earnings Before Interest, Taxes,
                                     
Depreciation & Amortization
 
$
(409
)
$
(518
)
$
109
 
$
618
 
$
411
 
$
207
 


  
-26-



Healthcare

Revenue
Total revenue increased $9,047,000 during the first six months of 2005 to $19,717,000 as the result of the inclusion of the DHI operations in the condensed consolidated results of operations for the full six month period ended June 30, 2005, as compared to only a full second quarter in 2004 plus seven days after the date of acquisition in the first quarter of 2004 being included in the six month period ended June 30, 2004.

Cost of sales/Gross profit
The cost of sales increased $6,384,000 during the first six months of 2005 to $13,326,000 as the result of the inclusion of the DHI operations in the condensed consolidated results of operations for the full six month period ended June 30, 2005, as compared to only a full second quarter in 2004 plus seven days after the date of acquisition in the first quarter of 2004 being included in the six month period ended June 30, 2004.

Gross profit was $6,391,000 or 32.4% of revenue during the first six months of 2005 as compared to $3,728,000 or 34.9% of revenue during the first six months of 2004. The increase of $2,663,000 was primarily the result of the inclusion of the DHI operations in the condensed consolidated results of operations for the full six month period ended June 30, 2005, as compared to only a full second quarter in 2004 plus seven days after the date of acquisition in the first quarter of 2004 being included in the six month period ended June 30, 2004. The reason for the decrease in the gross profit percentage is due to a decline of 4% in the gross profit percentage in the infusion services business as a result of lower margin therapies, combined with a decrease of 1% in the gross profit percentage at the retail pharmacies as a result of increased inventory shrinkage.

Operating expenses
Operating expenses increased $2,854,000 from $3,577,000 during the first six months of 2004 to $6,431,000 during the first six months of 2005. The increase was primarily the result of the inclusion of the DHI operations in the condensed consolidated results of operations for the full six month period ended June 30, 2005, as compared to only a full second quarter in 2004 plus seven days after the date of acquisition in the first quarter of 2004 being included in the six month period ended June 30, 2004.

 Depreciation and amortization
Depreciation and amortization expense increased $102,000 from $69,000 during the first six months of 2004 to $171,000 during the first six months of 2005. The increase was primarily the result of the inclusion of the DHI operations in the condensed consolidated results of operations for the full six month period ended June 30, 2005, as compared to only a full second quarter in 2004 plus seven days after the date of acquisition in the first quarter of 2004 being included in the six month period ended June 30, 2004. The increase includes $90,000 of amortization of patient prescriptions which were recorded as an intangible asset acquired in the acquisition of the Park Assets. This intangible asset is being amortized over 3 years. The comparable amortization expense recorded during the first six months of 2004 was $19,000. The increase in amortization results from adjustments to increase the purchase price of the Park assets by $311,000 during the third and fourth quarters of 2004 for acquisition costs and adjustments to the fair value of receivables at the acquisition date.

Interest expense, net
Net interest expense was $169,000 for the first six months of 2005 compared to net interest expense of $109,000 for the first six months of 2004. The increase in net interest expense, was primarily the result of the inclusion of the DHI operations in the condensed consolidated results of operations for the full six month period ended June 30, 2005, as compared to only a full second quarter in 2004 plus seven days after the date of acquisition in the first quarter of 2004 being included in the six month period ended June 30, 2004. The increase in net interest expense is net of a decrease of $18,000 in net interest expense during the second quarter of 2005 as compared to the second quarter of 2004, due to a decrease in the outstanding notes payable balances due to Bank of Texas and AmerisourceBergen.
 

  
-27-


Real Estate Advisory Services

Revenue
Revenue increased $3,061,000 from $3,067,000 during the first six months of 2004 to $6,128,000 during the first six months of 2005. The revenue for the first six months of 2004 included fee revenue of $682,000 earned by CRESA Capital Markets, compared to corresponding fee revenue of $17,000 earned by CRESA Capital Markets for the first six months of 2005. The remaining $2,385,000 of real estate advisory services revenue for the first six months of 2004 represented fee revenue earned by CPOC for the period from the date of acquisition on May 1, 2004 through June 30, 2004. CPOC earned fee revenue of $6,111,000 during the first six months of 2005.

Cost of Sales/Gross profit
Cost of sales was $3,832,000 for the first six months of 2005, representing 62.5% of revenue, compared to $1,521,000 or 49.6% of revenues for the first six months of 2004. Cost of revenue includes all direct costs, including broker commissions, incurred in connection with a real estate advisory transaction. The increase of $2,311,000 in cost of revenue over the first six months of 2004 is due primarily to the inclusion of CPOC’s cost of revenue for a full six months ending June 30, 2005, as compared to only two months for the six months ending June 30, 2004. CPOC was acquired by the Company on May 1, 2004. The increase of 12.9% in cost of sales as a percentage of revenue is primarily due to an increase in the percentage commission paid to brokers after the broker reaches a cumulative targeted revenue level.

Operating Expenses
Operating expenses increased $774,000 from $804,000 during the first six months of 2004 to $1,578,000 during the first six months of 2005. This increase is net of a decrease of $185,000 in selling, general and administrative expenses at Capital Markets due mostly to professional bonuses paid in the first six months of 2004 from fees received in connection with a completed real estate advisory transaction. There were no professional bonuses paid on real estate advisory services transactions at Capital Markets in the first six months of 2005. The increase in operating expenses also includes an increase of $831,000 during the first six months of 2005 as compared to the first six months of 2004 due to the inclusion of CPOC’s selling, general and administrative expenses and depreciation and amortization of $143,000 for a six months ending June 30, 2005, as compared to only two months for the six months ending June 30, 2004. CPOC was acquired by the Company on May 1, 2004.

Depreciation and amortization
Depreciation and amortization expense increased $128,000 during the first six months of 2005 as compared to the first six months of 2004. The increase is due to the inclusion of CPOC’s depreciation and amortization for a full six months ending June 30, 2005, as compared to only two months for the six months ending June 30, 2004. CPOC was acquired by the Company on May 1, 2004. The increase also includes $75,000 of amortization of non-compete agreements which were recorded as an intangible asset in connection with the acquisition of CPOC on May 1, 2004, which are being amortized over their contractual life of 3 years. There was no comparable amortization expense recorded for the first six months of 2004, as the Company did not complete its final allocation of the purchase price until the end of its 2004 fiscal year.

Interest expense, net
Interest expense, net is comprised of interest expense related to the debt assumed and incurred as part of the CPOC acquisition. Interest expense, net was $210,000 for the six months ending June 30, 2005, based on the Northern Trust Bank prime rate plus 0.50% on the $6.9 million outstanding balance of the CPOC Acquisition Note. The Northern Trust Bank prime rate was 6.25% at June 30, 2005. Interest expense, net was $65,000 for the six months ending June 30, 2004, and included interest expense incurred on the $6.9 million CPOC Acquisition Note, a $500,000 note payable to Kevin Hayes and a $500,000 line of credit payable to Northern Trust Bank. All of these notes payable bore interest at the Northern Trust Bank prime rate, which was 4.00% at June 30, 2004. The increase is also partially due to the inclusion of CPOC’s interest expense for a full six months ending June 30, 2005, as compared to only two months for the six months ending June 30, 2004. CPOC was acquired by the Company on May 1, 2004. The interest expense incurred on the Acquisition Note Payable to Kevin Hayes was $210,000 for the first six months of 2005 as compared to $53,000 for the first six months of 2004.
 

  
-28-


State income tax expense
The state income tax expense was $77,000 for the first six months of 2005 as compared to only $48,000 for the first six months of 2004. This increase is due to California state income tax expense of CPOC for the full six months ending June 30, 2005, as compared to only two months for the six months ending June 30, 2004. CPOC was acquired by the Company on May 1, 2004. The pretax earnings of CPOC for purposes of calculating California state income tax expense was $692,000 for the six months ending June 30, 2005 as compared to $512,000 for the six months ending June 30, 2004. The Company’s net operating loss carryforwards for Federal and state income tax purposes does not contain any loss carryforwards available to offset California state income taxes.

Corporate & Other

Operating expenses
Operating expenses decreased $52,000 from $656,000 during the first six months of 2004 to $604,000 during the first six months of 2005. The decrease is primarily comprised of (i) an increase in selling, general and administrative expenses of $75,000 due to increased payroll from one additional professional staff in the first six months of 2005, (ii) a decrease in accounting, legal and other professional fees of $151,000 as a result of fees related to two acquisitions in 2004, and (iii) an increase of $24,000 due to increases in rent, insurance and directors fees.

 Investment income
Investment income was $190,000 during the first six months of 2005 and included $95,000 of income from distributions received from the Company’s Fairways 03 New Jersey, LP investment compared to $101,000 for the first six months of 2004. The Company received distributions of $78,000 from Ampco during the first six months of 2005, of which $60,000 was recorded as investment income representing the Company’s investment share of Ampco earnings and $18,000 was recorded as a reduction of the Company’s investment asset in Ampco. During the first six months of 2004, the Company received distributions of $57,000 from Ampco, of which $39,000 was recorded as investment income representing the Company’s investment share of Ampco earnings and $18,000 was recorded as a reduction of the Company’s investment asset in Ampco.

Liquidity and Capital Resources
 
As of June 30, 2005, we had working capital of approximately $4.9 million as compared to approximately $6.2 million at December 31, 2004. The decrease is primarily the result of investments in Fairways Frisco, L.P. and the payment of accrued expenses.

As of June 30, 2005, we had cash and cash equivalents of approximately $1.2 million as compared to approximately $1.9 million at December 31, 2004. The decrease is primarily the result of an increase from cash flow provided from operating activities for the six month period ended June 30, 2005 of $752,000, offset by decreases from cash used in investing activities and financing activities of $1,283,000 and $98,000, respectively. Cash used in investing activities was due to investments in the Fairways Frisco, L.P. of $845,000 and purchases of property and equipment of $456,000. The property and equipment purchases include $245,000 related to the remodeling of one of DHI’s specialty pharmacy locations.

Through June 30, 2005, we had invested approximately $1,000,000 in Fairways Frisco, which represents the full amount of our expected investment. The Frisco Square Partnerships will require additional funding from Fairways Frisco in order to continue development of its real estate. However, we are not obligated to invest any additional funds if Fairways Frisco makes a capital call for additional cash, although we may choose to do so depending on our available funds. However, if we do not participate in additional capital calls, our limited partnership interest will be diluted.

Our future capital needs are uncertain. Although management projects positive cash flow after debt service based on anticipated operations of our recently acquired businesses, there can be no assurances that this will occur. The Company may or may not need additional financing in the future to fund operations. We do not know whether additional financing will be available when needed, or that, if available, we will obtain financing on terms favorable to stockholders.

  
-29-



Cash Flow

Since December 31, 2004, our cash balances have decreased by approximately $629,000. This decrease is primarily due to our purchases of property and equipment and investments in Fairways Frisco described above. We had positive cash flow from operations of $752,000 for the first six months of 2005 compared to $1,577,000 in the first six months of 2004.

Tax Loss Carryforwards

At December 31, 2004, we had approximately $49 million of federal net operating loss carryforwards and $39 million of state net operating loss carryforwards available to offset future taxable income, which, if not utilized, will fully expire from 2018 to 2023. We believe that the issuance of shares of our common stock pursuant to our initial public offering on November 15, 1999 caused an “ownership change” for purposes of Section 382 of the Internal Revenue Code of 1986, as amended. Consequently, we believe that the portion of our net operating loss carryforwards attributable to the period prior to November 16, 1999 is subject to an annual limitation pursuant to Section 382. Our total deferred tax assets have been fully reserved as a result of the uncertainty of future taxable income. Accordingly, no tax benefit has been recognized in the periods presented.

Off Balance Sheet Arrangements

The Company has guaranteed the CPOC Acquisition Note (as more fully described in the Company’s Form 10-K for the year ended December 31, 2004) in the amount of $ 6.9 million in connection with its acquisition of CRESA Partners of Orange County, Inc. on May 1, 2004. The Acquisition Note is payable from the excess cash flows of ASDS over a three year period. During the six month period ended June 30, 2005, there were no principal payments on the Acquisition Note and there were no payments required under the terms of the Company’s guarantee.

In January 2005, the Company agreed to provide a limited indemnification to its partners in the Fairways 03 New Jersey LP investment for any losses those partners may incur under their personal guaranties of the partnership’s bank indebtedness. The Company’s partners in this investment are the Fairways Members. The Company’s indemnification to these 4 partners is limited to $520,000 in the aggregate, which is its 20% pro rata partnership interest of the $2.6 million in bank debt that was guaranteed by the individuals. The Company estimated its obligation under this indemnification to be $220,000 and recorded this amount as a contingent liability and an increase to its investment in limited partnerships. At the present time, the Company does not believe it is probable that any defaults will occur on the bank debt subject to this guaranty and indemnification. As discussed in Note 14 to the condensed consolidated financial statements contained herein, the real estate property owned indirectly by Fairways 03 New Jersey LP is under option to be sold in December 2005. The proceeds from sale, if the purchase option is exercised by the buyer, would be used to pay off the $2.6 million in bank debt and the Company would have no further obligation under the indemnification agreement.

Disclosures About Contractual Obligations and Commercial Commitments
 
A summary of our contractual commitments under debt and lease agreements and other contractual obligations at June 30, 2005 and the effect such obligations are expected to have on liquidity and cash flow in future periods appears below. This is all forward-looking information and is subject to the risks and qualifications set forth at the beginning of Item 2.

  
-30-







   
Contractual Obligations As of June 30, 2005
 
   
Payments due by Period
 
   
Less than
 
1-3
 
3-5
 
More than
     
   
1 year
 
Years
 
Years
 
5 years
 
Total
 
                       
Lease Obligations
 
$
1,543,000
 
$
2,304,000
 
$
1,458,000
 
$
260,000
 
$
5,565,000
 
Notes Payable
   
481,000
   
11,266,000
   
541,000
   
-
   
12,288,000
 
                                 
Total
 
$
2,024,000
 
$
13,570,000
 
$
1,999,000
 
$
260,000
 
$
17,853,000
 

                         
Critical Accounting Policies

 The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to long-term investments. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.   We believe the following accounting policies and the related judgments and estimates affect the preparation of our consolidated financial statements.

Long-Term Investments  
Investments in limited partnerships include our investments in Ampco and Fairways Frisco, and none represent investments in publicly traded companies. The investment in Ampco is accounted for using the equity method of accounting for investments. The equity method is used as we do not have a majority interest and do not have significant influence over the operations of Ampco. Distributions received are recorded as investment income on the condensed consolidated statement of operations to the extent the distribution does not exceed our proportionate share of the investee’s earnings. Distributions in excess of our proportionate share are recorded as a reduction of our investment. 

We utilize the cost method to account for our investment in Fairways Frisco, L.P. Our ownership is less than 15% and we do not have any involvement in, nor do we exercise significant influence over the operations of Fairways Frisco, L.P. The Frisco Square Partnerships will require additional funding from Fairways Frisco in order to continue development of its real estate. However, we are not obligated to invest any additional funds if Fairways Frisco makes a capital call for additional cash. We expect our ownership percentage in Fairways Frisco will decline further if additional capital calls are received for Fairways Frisco’s funding needs and we do not fund our pro-rata share of such funding needs. Management believes that the cost method of accounting for its investment in Fairways Frisco, L.P. provides an accurate reflection of the nature of its investment and the current and future economic interest of the investment. As such, the investment is recorded at its actual cost. Any distributions received from Fairways Frisco, L.P. will be recorded as income when received. However, we do not expect to receive any distributions from Fairways Frisco, L.P. for the foreseeable future.


  
-31-


Recent Accounting Pronouncements.

A discussion of recent accounting pronouncements applicable to the Company is included in the Company’s Form 10-K for the year ended December 31, 2004.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We currently do not engage in commodity futures trading or hedging activities and do not enter into derivative financial instrument transactions for trading or other speculative purposes. We also do not currently engage in transactions in foreign currencies or in interest rate swap transactions that could expose us to market risk.  
 
We are exposed to market risk from changes in interest rates with respect to the credit agreements entered into by our subsidiaries to the extent that the pricing of these agreements is floating. We are exposed to interest rate risk primarily as the guarantor of ASDS’s Acquisition Note, which bears interest payable monthly at the prime rate of Northern Trust Bank plus 0.50% per annum. If the effective interest rate under the Acquisition Note were to increase by 100 basis points (1.00%), our annual financing expense would increase by approximately $69,000, based on the average balance outstanding under the Acquisition Note during the three month period ended June 30, 2005. A 100 basis points (1.00%) increase in market interest rates would decrease the fair value of our fixed rate debt by approximately $95,000. We did not experience a material impact from interest rate risk during the three month and six month periods ended June 30, 2005, respectively.

In addition, our ability to finance future acquisitions through debt transactions may be impacted if we are unable to obtain appropriate debt financing at acceptable rates. We are exposed to market risk from changes in interest rates through our investing activities. Our investment portfolio consists primarily of investments in high-grade commercial bank money market accounts.

The following table summarizes the financial instruments held by us at June 30, 2005, which are sensitive to changes in interest rates. At June 30, 2005, approximately 56.2% of our debt was subject to changes in market interest rates and was sensitive to those changes. Scheduled principal cash flows for debt outstanding at June 30, 2005 for the twelve months ending June 30 are as follows:

   
 
     
   
Fixed Rate
 
Variable Rate
 
Total
 
               
2006
 
$
481,000
 
$
-
 
$
481,000
 
2007
   
4,319,000
   
6,900,000
   
11,219,000
 
2008
   
47,000
   
-
   
47,000
 
2009
   
541,000
   
-
   
541,000
 
2010
   
-
   
-
   
-
 
Thereafter
   
-
   
-
   
-
 
   
$
5,388,000
 
$
6,900,000
 
$
12,288,000
 

 
ITEM 4. CONTROLS AND PROCEDURES
 
Evaluation of Disclosure Controls and Procedures

As required by rule 13a-15(b), the Company, including the Chief Executive Officer and Chief Financial Officer, conducted an evaluation as of the end of the period covered by this report, of the effectiveness of the Company’s disclosure controls and procedures as defined in Exchange Act Rule 13a-15(e). Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report. As required by Rule 13a-15(d), the Company’s management conducted an evaluation of the Company’s internal control over financial reporting to determine whether changes occurred during the first fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. Based on that evaluation, there has been no such change during the first six months of 2005.

  
-32-


 
It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system will be met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events.
 
However, due to the limited size of the Company’s staff, there is inherently a lack of segregation of duties related to the authorization, recording, processing and reporting of transactions. We will continue to periodically assess the cost versus benefit of adding the resources that would improve segregation of duties and currently, with the concurrence of the board of directors, do not consider the benefits to outweigh the costs of adding additional staff in light of the limited number of transactions related to the company’s operations.
 
 
PART II.
 
OTHER INFORMATION
 

Between January 23, 2001 and February 21, 2001, five putative class action lawsuits were filed in the United States District Court for the Northern District of Texas against us, certain of our directors, and a limited partnership of which a director is a partner. The five lawsuits assert causes of action under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, for an unspecified amount of damages on behalf of a putative class of individuals who purchased our common stock between various periods ranging from November 11, 1999 to January 24, 2000. The lawsuits claim that we and the individual defendants made misstatements and omissions concerning our products and customers. 

In April 2001, the Court consolidated the lawsuits, and on July 26, 2002, plaintiffs filed a Consolidated Amended Complaint (“CAC”). We filed a motion to dismiss the CAC on or about September 9, 2002. On July 22, 2003, the Court granted in part and denied in part defendants’ motion to dismiss. On September 2, 2003, defendants filed an answer to the CAC. Plaintiffs then commenced discovery. On September 12, 2003, plaintiffs filed a motion for class certification, and on February 17, 2004, we filed our opposition. On July 1, 2004, the Court denied plaintiffs’ motion for certification. On September 8, 2004, the Fifth Circuit granted plaintiffs’ petition for permission to appeal the denial of class certification. The parties have completed briefing and oral argument and the Fifth Circuit has not yet ruled on the appeal.

We continue to deny plaintiffs’ allegations and intend to vigorously defend ourselves. It is not possible at this time to predict whether we will incur any liability or to estimate the damages, or the range of damages, if any, that we might incur in connection with this lawsuit. Our insurance carriers are continuing to provide for the payment of our defense costs in connection with this case and intend to vigorously defend against the lawsuits.

We are also occasionally involved in other claims and proceedings, which are incidental to our business. We cannot determine what, if any, material affect these matters will have on our future financial position and results of operations.
 
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

We held our Annual Meeting of Stockholders on May 9, 2005. Proxies for the meeting were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended; there was no solicitation in opposition to management’s nominees as listed in the Proxy Statement and all such nominees were elected. The following matter was acted upon and votes cast or withheld:

Stockholders approved the election of the following directors:

Class C Director
Shares Cast For
Shares Withheld From Voting For
James C. Leslie
19,300,248
1,830


  
-33-


The Class C Director will hold office until the annual meeting of stockholders in 2008 and until his successor is elected and qualified.

Directors continuing in office after the meeting were:

Class A Directors
David E. Bowe
Jonathan R. Bloch

Class B Directors
Anthony J. LeVecchio
Will Cureton

Class C Director
James C. Leslie

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
 
(a) Exhibits
 

 
3.1
Certificate of Incorporation of Ascendant Solutions, Inc. (incorporated by reference from Exhibit 3.1 to our Form 8-K filed October 23, 2000, File no. 0-27945).
 
 
3.2
Bylaws of Ascendant Solutions, Inc. (incorporated by reference from Exhibit 3.2 to our Form 8-K filed October 23, 2000, File no. 0-27945).

 

 _______________________________________________
* Filed herewith.
 
(b) Reports on Form 8-K
 
On April 29, 2005, the Company filed Amendment No. 2 to amend Item 1.01 of the Current Reports on Form 8-K filed on January 7, 2005 (the “Initial Report”), January 14, 2005, February 23, 2005 and March 16, 2005 to update the status of the capital contributions to Fairways Frisco, L.P. and to describe the termination of the Master Agreement Regarding Frisco Square Partnerships on April 15, 2005, and Item 9.01 of the Initial Report to add the table reflecting certain ownership after giving effect to the Amendment as Exhibit 99.1.

On May 24, 2005, the Company filed a Current Report on Form 8-K to report the issuance of restricted common stock under the 2003 Equity Incentive Plan to its non-employee directors.

  
-34-


 




SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 




Date: August 15, 2005
 
ASCENDANT SOLUTIONS, INC.
     
 
 
 By:
 
/s/ David E. Bowe 
 
 
 
 
David E. Bowe
 
 
 
 
President and Chief Executive Officer
 
 
 
 
 (Duly Authorized Officer and Principal Executive Officer)

Date: August 15, 2005
 
ASCENDANT SOLUTIONS, INC.
     
 
 
 By:
 
/s/ Gary W. Boyd 
 
 
 
 
Gary W. Boyd
 
 
 
 
Vice President-Finance and Chief Financial Officer
 
 
 
 
 (Duly Authorized Officer and Principal Financial Officer)
 
 
 
 
 
 
 
 
 
-35-